Sublingual Semaglutide/Ondansetron (Rapid Dissolving Tablets)

$159.00$669.00

This innovative sublingual rapid disintegrating tablet (RDT) combines Semaglutide, a GLP-1 receptor agonist, with Ondansetron, an anti-nausea medication, to support weight management while minimizing gastrointestinal side effects. Semaglutide helps regulate appetite, improve insulin sensitivity, and promote weight loss, while Ondansetron reduces nausea, a common side effect of GLP-1 therapy. Designed for sublingual absorption, this formulation dissolves under the tongue for enhanced bioavailability and convenience, offering an alternative to injectable therapy. In collaboration with a network of licensed medical providers, we offer comprehensive therapy plans that may include this compounded medication, ensuring individualized care under professional medical supervision.

Important Information & Disclaimer:
Compounded drug products are not approved or evaluated for safety, efficacy, or quality by the FDA. If a brand-name product exists, it has undergone FDA review; any questions about FDA approval should be discussed with your healthcare provider.
These statements have not been evaluated by the Food and Drug Administration. Please consult with your licensed medical provider for individualized medical advice

This service requires a prescription from a Valhalla Vitality provider. To get started, please create an account.

Description

Sublingual Semaglutide & Ondansetron (Rapid Disintegrating Tablet)

Description

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood sugar levels, enhance insulin sensitivity, and promote weight loss by reducing appetite and slowing digestion. However, some individuals may experience nausea as their body adjusts to GLP-1 therapy.

To improve patient tolerance, this sublingual rapid disintegrating tablet (RDT) includes Ondansetron, a well-known anti-nausea medication, to help reduce nausea and improve overall adherence to treatment. Unlike traditional oral tablets that must be swallowed and absorbed through the digestive system, this sublingual formulation is placed under the tongue, where it dissolves quickly for direct absorption into the bloodstream. This method allows for faster onset and improved bioavailability, making it an excellent alternative for those who prefer to avoid injections.

In collaboration with a network of licensed medical providers, we offer personalized therapy plans that may include Semaglutide & Ondansetron Sublingual RDT, ensuring safe and effective treatment under medical supervision.

Key Features

  • Sublingual Therapy for Enhanced Absorption: Dissolves under the tongue for rapid and direct uptake, bypassing the digestive system.
  • Supports Weight Loss: Semaglutide helps regulate appetite and improve metabolic function.
  • Minimizes Nausea & GI Discomfort: Ondansetron helps counteract nausea, a common side effect of GLP-1 therapy.
  • Alternative to Injections: Ideal for individuals preferring a non-injectable formulation.
  • Expert Medical Oversight: Providers assess individual needs and adjust therapy accordingly.

Important Information & Disclaimer

  • Compounded Medications: Compounded drug products are not approved or evaluated for safety, efficacy, or quality by the FDA. However, our partner pharmacies are licensed by the Board of Pharmacy and comply with FDA regulations under 503A and 503B.
  • Medical Supervision: Always consult a qualified healthcare professional regarding your personal health situation and the suitability of Semaglutide & Ondansetron Sublingual Therapy.
  • No Claims of Cure: This therapy is not intended to diagnose, treat, cure, or prevent any disease.

If you’re ineligible to receive therapy or medications after consultation with a Valhalla Vitality provider – you will be fully refunded!

Book a consultation to speak to a provider about treatment options.